Bangladesh Proposes to Ban Safer Nicotine Products Under Foreign Influence, Ignoring Public Health Evidence and Regional Precedents
Citing WHO FCTC Article 5.3, the Ministry is attempting to justify excluding public health experts, consumers, and harm reduction advocates from the policymaking process. According to a report by the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), this misuse of international guidance is designed to block dissent and suppress scientific debate.
The proposal appears to be heavily influenced by foreign actors—most notably Bloomberg Philanthropies and its primary grantee, the U.S.-based Campaign for Tobacco-Free Kids (CTFK). Since 2008, Bloomberg Philanthropies has channelled over US$232 million to CTFK to promote anti-nicotine policies worldwide. These funds support NGOs, train bureaucrats, and embed advisors within government ministries, creating a network of influence that sidelines national sovereignty.
In Bangladesh, Bloomberg partner Vital Strategies maintains a Dhaka office staffed by former government officials, while CTFK and its affiliates are listed as official partners of the Ministry's National Tobacco Control Cell. This arrangement allows foreign-funded groups to shape policy directly, with little regard for democratic process or public health realities on the ground.
'This is not tobacco control. This is policy outsourcing,' said Nancy Loucas, Executive Coordinator of CAPHRA. 'Bangladesh risks allowing foreign-funded NGOs to override its own democratic institutions and deny its citizens access to proven harm reduction tools.'
The move contradicts regional trends. Similar foreign-backed proposals were recently rejected in Pakistan and the Philippines , where authorities prioritized evidence-based public health approaches over external influence.
The dangers of banning SNPs are already visible elsewhere. Countries like India and Australia, which have implemented such bans, are now dealing with rampant black markets and unregulated products—problems that undermine rather than improve public health.
With one of the highest rates of tobacco-related illness in the world, Bangladesh stands to benefit greatly from a regulated harm reduction strategy. The global evidence is clear: SNPs help smokers quit and significantly reduce harm. A blanket ban would be a step backward, not forward.
Contact:
N.E Loucas
[email protected] WhatsApp: 64 0272348463
www.caphraorg.net
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
AI in Telehealth & Telemedicine Market worth $27.14 Billion by 2030 with 36.4% CAGR
DELRAY BEACH, Fla., July 29, 2025 /PRNewswire/ -- The global AI in Telehealth & Telemedicine Market, valued at US$2.85 billion in 2023 stood at US$4.22 billion in 2024 and is projected to advance at a resilient CAGR of 36.4% from 2024 to 2030, culminating in a forecasted valuation of US$27.14 billion by the end of the period. The market has experienced significant growth primarily driven by the growing geriatric and medically underserved (predominantly rural) population, the increasing prevalence of chronic conditions, the shortage of physicians and care personnel, advancements in telecommunication technologies, and the expansion of RPM systems. However, the growing use of wearables, apps, and sensors for virtual care, the increasing shift towards outpatient care models, and the high utility of telemedicine against infectious diseases and epidemics are significant opportunities in the market. Download PDF Brochure: Browse in-depth TOC on "AI in Telehealth & Telemedicine Market" 409 - Tables58 - Figures380 - Pages By application, the primary care segment commanded the most significant proportion of the AI in telemedicine market due to an increased need for day-to-day healthcare, such as check-ups, chronic condition management, and preventive care, well-suited for AI implementation. These platforms leverage AI to automate symptom evaluation, virtual consultations, and follow-ups to make healthcare more accessible and convenient for day-to-day health issues. Organizations such as Hellocare (US) provide a complete telehealth platform with AI-based solutions for primary care, including virtual patient observation and RPM. These solutions increase patient engagement and simplify care delivery. Furthermore, CVS Health (US) provides CVS Health Virtual Primary Care by providing personalized digital healthcare services, enabling users to access and manage their health remotely. By function, the remote patient monitoring segment is expected to be the fastest-growing segment of AI in telehealth market by function due to the increasing number of chronic diseases (including diabetes, hypertension, and CVDs) that need constant monitoring and management. RPM systems constantly monitor patient health data, eliminating the need for many hospital visits and improving patient outcomes. Many healthcare facilities, such as Mayo Clinic (US), offer RPM systems to reduce readmission rates. In January 2025, Taiwan's Industrial Technology Research Institute (ITRI) introduced AI-based RPM devices that were developed in partnership with StreamTeck (Taiwan) to detect patient vitals (body temperature, heart rate, and blood pressure). By geography, North America accounted for the largest market share due to the region's modern healthcare infrastructure, the widespread use of advanced technologies, and extensive governmental support. The US, especially, has adopted favorable reimbursement policies and regulatory mandates, including those from the Centers for Medicare & Medicaid Services (CMS), to increase telehealth access and RPM technology. Favorable government initiatives have also propelled market growth. In October 2023, the American Telemedicine Association published a new AI principle to advance the safe, appropriate, and responsible use of AI in healthcare that enhances patient and provider trust, safety, and the efficacy of AI adoption as a tool in healthcare. Numerous US-based companies provide AI-based telehealth & telemedicine solutions—in October 2024, Zoom Communications (US) partnered with Suki AI, Inc. (US) to implement AI-powered voice tools within their telehealth services to improve clinical documentation functionalities. Together, these factors enhance North America's leadership in the AI in telehealth & telemedicine market. Request Sample Pages : Prominent players in the telehealth & telemedicine market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), American Well (US), Siemens Healthineers AG (Germany), and Cisco Systems Inc. (US), among others. Koninklijke Philips N.V (Netherlands) Koninklijke Philips N.V. is a diversified technology-based company in the AI in telehealth markets. It is one of the leading companies in the healthcare sector with a strong presence in cardiac care, acute care, and home healthcare. The company operates through four segments: Personal Health, Diagnosis & Treatment, Connected Care, and Others. The AI-based telehealth & telemedicine services fall under the Connected Care segment. The Connected Care segment comprises Business Monitoring, Sleep & Respiratory Care, and Enterprise Informatics. Providers and patients use telehealth solutions. The company operates in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In November 2024, Philips received FDA approval for remote scanning and protocol management features in its Radiology Operations Command Center (ROCC), allowing radiologists to assist with scans remotely. Medtronic (Ireland) Medtronic (Ireland) is one of the largest medical technology, services, and solutions companies. The company operates through four principal segments: Cardiovascular, Diabetes, Medical Surgical, and Neuroscience. The company provides AI-based telemedicine solutions across all four segments. The Cardiac and Vascular segment offers products and services to diagnose, treat, and manage cardiac rhythm disorders and CVDs. Medtronic's portfolio encompasses RPM platforms and patient-centered software through its products and Medtronic Care Management Services. The telehealth solutions offered by the company cover glucose management and cardiac condition management. Medtronic's telehealth device offerings include Bluetooth-enabled and direct-connect peripherals. These devices comprise weight scales, glucometers, blood pressure monitors, pulse oximeters, pedometers, and activity trackers. Medtronic serves its customers in ~160 countries worldwide. The company operates in North America, Latin America, Europe, the Asia Pacific, the Middle East & Africa, and Russia. Epic Systems Corporation (US) Epic Systems Corporation (US) is a software development, installation, and support company that provides consulting services. The company establishes healthcare management software that combines financial and clinical information from inpatient, ambulatory, and payer technology systems. The company's core competency is to provide EHR software solutions. Epic Systems Corporation integrates AI into telehealth & telemedicine through strategic partnerships with Microsoft and Gen AI technologies. Epic improves productivity and patient care in virtual healthcare by combining its EHR solutions with Microsoft's Azure OpenAl Service. It encompasses improving workflows, enabling generative Al to compose message responses, and supporting natural language queries. Epic's AI efforts also enhance self-service reporting tools, maintain financial integrity, and improve clinical outcomes, all of which will enhance global telehealth & telemedicine systems. It operates its offices in the US, the UK, Canada, Denmark, the Netherlands, Norway, Saudi Arabia, the UAE, Finland, Ireland, Australia, Singapore, and Switzerland. For more information, Inquire Now! Related Reports: Telehealth & Telemedicine Market Home Healthcare Market Healthcare IT Market Remote Patient Monitoring (RPM) Market IoT Medical Devices Market Get access to the latest updates on AI in Telehealth & Telemedicine Companies and AI in Telehealth & Telemedicine Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets
CNN
2 hours ago
- CNN
US to burn $9.7 million worth of USAID-purchased contraceptives rather than deliver them to women overseas
The Trump administration is set to destroy $9.7 million worth of US-purchased contraceptives rather than deliver them to women overseas, following the dismantling of foreign assistance programs carried out by the US Agency for International Development, or USAID. The 'preliminary decision' to destroy the USAID-procured birth control was confirmed by a State Department spokesperson, who said the cost of incinerating them would be $167,000. The contraceptives have been housed in a warehouse in Geel, Belgium. The Belgian foreign ministry said it was engaged in diplomatic talks with the US embassy to work to find alternative solutions for the supplies. The contraceptives are mostly long-lasting types of birth control, such as intrauterine devices (IUDs) and injectables, a US congressional aide told CNN. It is not clear exactly when the supplies will be destroyed, according to the aide. 'They have to double incinerate the products because they contain high levels of hormones and they don't want to risk leaking the byproducts out in the environment, which likely adds to the cost,' the congressional aide said. 'The Trump administration is quite literally burning taxpayer money.' A list of the supplies, shared with CNN by another source with knowledge of the warehouse stock, shows that the contraceptives include copper IUDs, rod implants, birth control injections, and levonorgestrel and ethinyl estradiol tablets. Some have USAID branding but the majority do not, according to the source's list. Most of the products expire in 2028 or 2029, with the earliest expiration date among the products in April 2027, according to the list detailing the nearly 5 million items. The US State Department spokesperson referred to the contraceptives to be destroyed as 'certain abortifacient birth control commodities from terminated Biden-era USAID contracts.' There is controversy about whether to describe certain contraceptives as abortifacient, or causing abortion, due to the debate over whether life begins at the moment an egg is fertilized or at a later stage. Some birth control methods, including IUDs, may work by preventing implantation of a fertilized egg. However, IUDs primarily work by suppressing the release of eggs, or by preventing sperm from reaching an egg. CNN has approached the American College of Obstetricians and Gynecologists for comment. 'Only a limited number of commodities have been approved for disposal. No HIV medications or condoms are being destroyed,' the spokesperson added. 'USAID avoided an additional $34.1 million in taxpayer costs by negotiating no-cost cancellations of pending orders placed under the Biden Administration.' Responding to media reports that the contraceptives were set to be transferred to a French medical waste facility to be destroyed by the end of July, a diplomatic source in France told CNN that the contraceptives were being handled by private entities and they had 'no information concerning any transfers,' as of Thursday last week. 'We firmly support the Belgian authorities' commitment to find a solution in order to prevent the destruction of these contraceptives, so that they may reach women and men around the world who need them and are waiting for them,' the diplomatic source added. 'Access to quality sexual and reproductive health services and products is both a human rights and a public health issue.' US Senator Jeanne Shaheen (D-NH) sent a staff member to the warehouse in Belgium as part of her effort to introduce legislation prohibiting 'the destruction of any such commodities unless all efforts to sell or donate them have been exhausted.' The staffer also found that the earliest expiration date for the contraceptives was 2027, with some of the supplies not expiring until 2031, meaning they could still be used for years to come. 'At a moment when the Trump administration has made devastating cuts to foreign assistance it is disappointing that the State Department would sign off on spending money to actually destroy paid-for commodities that would save lives and are waiting to be deployed,' Shaheen said in a statement. 'Food and family planning commodities are desperately needed in conflict affected countries, like Sudan and the Democratic Republic of Congo where famine is taking hold.' Belgian foreign ministry spokeswoman Florinda Baleci told CNN the country was 'exploring all possible avenues to prevent the destruction of these stocks, including their temporary relocation.' An organization called MSI Reproductive Choices said it and other funding partners had offered to pay for the shipping and repackaging of the USAID-branded supplies, but that the US government turned down the offer. 'We were not given a reason for why this offer was not accepted, but it became clear in conversations that it wouldn't be and that our efforts would be better spent finding alternative solutions to the contraception supplies gap,' said Grace Dunne, a spokeswoman for MSI, which works in 36 countries to provide reproductive healthcare, including abortion services, contraception and maternity care. In response to questions about the offer from CNN, the State Department highlighted the so-called 'Mexico City policy,' which 'prohibits providing certain assistance – directly or indirectly – to foreign nongovernmental organizations that perform or actively promote abortion as a method of family planning.' That policy, which opponents call the 'global gag rule,' prevents non-governmental organizations that provide abortions, give counseling about abortions or advocate for safe access to abortion from receiving US funding. The planned destruction of the contraceptives has sparked an outcry from other organizations, like Doctors Without Border (MSF), which raised concerns about contraceptive shortages in nations that were once reliant on supplies donated by USAID. 'In the communities served by MSF – whether impacted by conflict, disease outbreaks, natural and human-made disasters, or exclusion from health care – access to contraceptives is already constrained,' the organization said in a statement. 'Contexts that previously relied upon USAID funded contraceptive supplies are at a heightened risk of supply chain disruptions and stockouts.' 'MSF has seen firsthand the positive health benefits when women and girls can freely make their own health decisions by choosing to prevent or delay pregnancy – and the dangerous consequences when they cannot,' the chief executive of MSF USA, Avril Benoît, added. MSF also cited reports saying that more USAID-branded contraceptives are being housed in a warehouse in the United Arab Emirates, but the organization said the US government's plan for those supplies is unknown. A State Department spokesperson did not address a question about contraceptives warehoused in the UAE. CNN has reached out to the UAE government for comment. At the beginning of July, US Secretary of State Marco Rubio hailed the end of USAID, saying that future foreign assistance programs would align with administration policies and be administered by the State Department. The rapid dismantling of USAID, led by the Department of Government Efficiency (DOGE), has seen thousands of foreign assistance programs slashed, including many that focused on lifesaving work. A study published earlier this month by a leading medical journal, The Lancet, estimated that the USAID funding cuts could result in more than 14 million additional deaths by 2030. USAID funding was most likely to reduce mortality related to HIV/AIDS, followed by malaria, according to the study.
Medscape
6 hours ago
- Medscape
Do Medical Students With Disabilities Face Discrimination?
TOPLINE: Disability-based discrimination was reported by 12.4% of medical students with disabilities in the US, with the highest rates being reported by those with chronic illnesses and multiple disabilities. Clinical clerkship faculty and residents were frequently cited as sources of discrimination. METHODOLOGY: Researchers analyzed data from the 2024 Association of American Medical Colleges (AAMC) Graduation Questionnaire, completed by 80% of graduates, to understand the prevalence and sources of disability-based discrimination among 1800 students with disabilities. Disability status was self-reported and categorized as nondisabled, learning disabilities, psychological issues, motor or sensory disabilities, chronic illness, multiple types, and other. The questionnaire assessed the sources and frequency of discrimination on the basis of experiences such as being denied opportunities for training, receiving poorer evaluations, and facing offensive remarks related to disabilities. Multiple experiences of discrimination were coded as two or more types, such as denied opportunities and offensive remarks. TAKEAWAY: Overall, 12.4% of students with disabilities reported experiencing discrimination, with those having chronic illnesses, motor or sensory disabilities, and multiple disabilities reporting the highest rates of discrimination (P < .001 for all). Clinical clerkship faculty and residents were the most frequently cited sources of discrimination, affecting evaluations (74.8% and 36.5%, respectively) and opportunities (58.9% and 28.9%, respectively). The most commonly cited sources of offensive remarks were clinical clerkship faculty (51.6%), residents (30.6%), and students (19.8%). IN PRACTICE: 'To address these issues, programs should foster an inclusive clinical educational culture, where students are empowered to report discrimination without fear of retaliation, train faculty and residents on disability awareness and inclusive teaching strategies, and learning happens in universally designed settings,' the authors of the study wrote. 'Ensuring that faculty understand the concept and goals of reasonable accommodations is important; resources offered by the AAMC can assist in these efforts. Involving medical students and faculty with disabilities and chronic disease in these efforts is essential and underscores the value of disability representation in medicine,' experts wrote in an invited commentary. SOURCE: The study was led by Mytien Nguyen, MS, of the Department of Immunobiology at the Yale University School of Medicine in New Haven, Connecticut. It was published online on July 28, 2025, in JAMA Internal Medicine. LIMITATIONS: The self-reported and cross-sectional data may have led to an underestimation of how often discrimination occurred and uncertainty about the exact causes of discriminatory experiences. DISCLOSURES: This work was supported by grants from the Ford Foundation; the National Institute on Disability, Independent Living, and Rehabilitation Research; the Robert Wood Johnson Foundation; the National Institute of General Medical Sciences; and the National Institute of Allergy and Infectious Diseases. One author reported receiving personal fees from Docs With Disabilities, and two authors reported receiving grants from the National Institutes of Health during the conduct of the study. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
